Pentazocine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for pentazocine hydrochloride and what is the scope of patent protection?
Pentazocine hydrochloride
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for pentazocine hydrochloride.
Summary for pentazocine hydrochloride
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Clinical Trials: | 11 |
| Patent Applications: | 1,557 |
| DailyMed Link: | pentazocine hydrochloride at DailyMed |
Recent Clinical Trials for pentazocine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal Medical Centre, Yenagoa | N/A |
| Olakunle Ifeoluwa Makinde | N/A |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for pentazocine hydrochloride
US Patents and Regulatory Information for pentazocine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | TALWIN 50 | pentazocine hydrochloride | TABLET;ORAL | 016732-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
